Moreover, low-dose clenbuterol stimulated basal in vivo glucose uptake in skeletal muscle and improved whole-body insulin sensitivity as well as reduced hepatic steatosis under chronic stimulation in DIO mice. This evidence concerns the gene INS and fatty liver disease.